Product Information
HALOPERIDOL DEC 50 MG/ML VIAL is a generic product labeled by Meitheal Pharmaceuticals Inc., priced at $6.5723 per ML under NDC 71288050202. Its NADAC has been published 144 times since Jun 8, 2022.
FDA first approved this application on Jul 26, 2021. Its Orange Book therapeutic-equivalence code is AO.
Strength
50 mg/mL
Manufacturer
Meitheal Pharmaceuticals Inc.NDC
71288050202
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOL DECANOATEApproval Type
Generic (ANDA)
FDA Application
ANDA214507FDA Approved
7/26/2021
TE Code
AO
On Market Since
7/26/2021
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL DEC 50 MG/ML VIAL has been published 144 times since Jun 8, 2022, and over the history we have for it it has declined 62.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.5723 per ML |
|---|---|
| All-time high | $17.6009 (Sep 14, 2022) |
| All-time low | $6.5723 (Sep 23, 2026) |
| 52-week high | $11.0822 |
| 52-week low | $6.5723 |
| Median price | $10.2595 |
| Average price | $10.4611 |
| Largest weekly change | -35.5% (Apr 17, 2024) |
| Weeks tracked | 144 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Meitheal Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Haloperidol Decanoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL DEC 50 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL DEC 50 MG/ML VIAL, manufactured by Meitheal Pharmaceuticals Inc., is $6.5723 per ML (NDC 71288050202), effective Sep 30, 2026.
How has the price of HALOPERIDOL DEC 50 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL DEC 50 MG/ML VIAL has declined 62.7%. It has been tracked across 144 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL DEC 50 MG/ML VIAL?
Since Jun 8, 2022, the NADAC for HALOPERIDOL DEC 50 MG/ML VIAL has ranged from a low of $6.5723 (Sep 23, 2026) to a high of $17.6009 (Sep 14, 2022), with a median of $10.2595 per ML.
Are there cheaper alternatives to HALOPERIDOL DEC 50 MG/ML VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HALOPERIDOL DEC 50 MG/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures HALOPERIDOL DEC 50 MG/ML VIAL?
HALOPERIDOL DEC 50 MG/ML VIAL (NDC 71288050202) is labeled by Meitheal Pharmaceuticals Inc., and CMS classifies it as a generic product.